We are live on ! Find out more
IMVT icon

Immunovant
IMVT

133 hedge funds and large institutions have $980M invested in Immunovant in 2022 Q4 according to their latest regulatory filings, with 39 funds opening new positions, 53 increasing their positions, 28 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

3,504% more call options, than puts

Call options by funds: $8.87M | Put options by funds: $246K

400% more funds holding in top 10

Funds holding in top 10: 1 → 5 (+4)

312% more capital invested

Capital invested by funds: $238M → $980M (+$742M)

117% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 18

89% more repeat investments, than reductions

Existing positions increased: 53 | Existing positions reduced: 28

19% more funds holding

Funds holding: 112 → 133 (+21)

7.16% more ownership

Funds ownership: 36.59% → 43.75% (+7.2%)

Holders
133
Holders Change
+21
Holders Change %
+18.75%
% of All Funds
2.14%
Holding in Top 10
5
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+400%
% of All Funds
0.08%
New
39
Increased
53
Reduced
28
Closed
18
Calls
$8.87M
Puts
$246K
Net Calls
+$8.62M
Net Calls Change
+$6.06M

Top Buyers

1
LGM
Logos Global Management
California
+$39.7M
2
BI
BVF Inc
California
+$32.2M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$31.3M
4
State Street
State Street
Massachusetts
+$28.1M
5
CAC
Cowen and Company
New York
+$15.7M

Top Sellers

1
AGM
Alpine Global Management
New York
-$35.9M
2
EAM
Eventide Asset Management
Massachusetts
-$21.1M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
-$19.3M
4
WP
Woodline Partners
California
-$11.9M
5
OCA
Octagon Capital Advisors
New York
-$3.23M
Name Holding Trade Value Shares
Change 		Change in
Stake
FRM
101
Fox Run Management
Connecticut
$227K +$161K +12,780 New
QT
102
Quantamental Technologies
New York
$218K +$155K +12,301 New
B
103
Bailard
California
$217K +$154K +12,200 New
VFA
104
Values First Advisors
Tennessee
$210K -$144K -11,399 -49%
EFM
105
E Fund Management
China
$209K +$149K +11,799 New
PP
106
PDT Partners
New York
$207K -$6.37K -506 -4%
Teacher Retirement System of Texas
107
Teacher Retirement System of Texas
Texas
$206K -$21.4K -1,702 -13%
ASRS
108
Arizona State Retirement System
Arizona
$194K -$1.83K -145 -1%
VEA
109
Virtus ETF Advisers
New York
$165K -$266K -21,091 -69%
Simplex Trading
110
Simplex Trading
Illinois
$150K -$13.7K -1,085 -11%
Zurich Cantonal Bank
111
Zurich Cantonal Bank
Switzerland
$129K -$9.87K -784 -10%
Public Employees Retirement Association of Colorado
112
Public Employees Retirement Association of Colorado
Colorado
$119K – – –
Royal Bank of Canada
113
Royal Bank of Canada
Ontario, Canada
$109K +$58.4K +4,635 +301%
Nisa Investment Advisors
114
Nisa Investment Advisors
Missouri
$104K +$491 +39 +0.7%
AB
115
Amalgamated Bank
New York
$104K +$9.62K +764 +15%
DA
116
Denali Advisors
California
$69.2K +$49.1K +3,900 New
Amundi
117
Amundi
France
$63.8K +$45.5K +3,616 New
TRCT
118
Tower Research Capital (TRC)
New York
$58K -$106K -8,436 -72%
AIP
119
Ameritas Investment Partners
Nebraska
$55.9K – – –
Osaic Holdings
120
Osaic Holdings
Arizona
$53K – – –
US Bancorp
121
US Bancorp
Minnesota
$52.5K +$19.9K +1,582 +115%
MLICM
122
Metropolitan Life Insurance Company (MetLife)
New York
$48.9K +$3.77K +299 +12%
Canada Life
123
Canada Life
Manitoba, Canada
$42K – – –
CUAMC
124
China Universal Asset Management Company
China
$23.3K +$2.77K +220 +20%
Dimensional Fund Advisors
125
Dimensional Fund Advisors
Texas
$23K +$3.01M +239,149 +23%
3 4
5
6 7

IMVT Hedge Fund Activity: Q4 2022 in Review

133 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Immunovant (IMVT) for Q4 2022, worth a combined $980M — up 312% from $238M a quarter earlier.

Buyers outnumbered sellers: 39 funds opened new IMVT positions and 18 closed out — a net gain of 21 holders — while 53 added to existing stakes and 28 trimmed.

The largest buyer was Logos Global Management, opening a new position worth an estimated $39.7M. The largest seller was Alpine Global Management, cutting an estimated $35.9M.

  • 133 institutional investors held Immunovant (IMVT) as of Q4 2022, up from 112 in Q3 2022.
  • Funds reported $980M of Immunovant stock for Q4 2022, up 312% quarter-over-quarter.
  • 39 funds opened new Immunovant positions in Q4 2022 and 18 closed out, a net change of +21 holders.
  • The largest Immunovant buyer in Q4 2022 was Logos Global Management, an estimated $39.7M added.
  • The largest Immunovant seller in Q4 2022 was Alpine Global Management, an estimated $35.9M sold.

Based on aggregated 13F filings for Q4 2022.